BRIEF-Jamjoom Pharma Q2 Profit SAR 137.63 Million

JAMJOOM PHARMA
Tadawul All Shares Index

JAMJOOM PHARMA

4015.SA

0.00

Tadawul All Shares Index

TASI.SA

0.00

July 22 (Reuters) - Jamjoom Pharmaceuticals Factory 4015.SE:

  • JAMJOOM PHARMA Q2 NET PROFIT SAR 137.63 MILLION

  • JAMJOOM PHARMA Q2 SALES SAR 445.31 MILLION

  • JAMJOOM PHARMA - QUARTER SAW HIGHER OPERATING EXPENSES

  • JAMJOOM PHARMA - QUARTER SAW LOWER OTHER INCOME AND LOWER INCOME FROM JOINT VENTURE

  • JAMJOOM PHARMA - QUARTER SAW HIGHER SELLING AND DISTRIBUTION EXPENSES

  • JAMJOOM PHARMA - QUARTER SAW MORE HIRING AND PROMOTIONAL ACTIVITY

  • JAMJOOM PHARMA - QUARTER SAW REVENUE INCREASED BY 8.5% TO SAR 926.7 MILLION, DRIVEN BY HIGHER VOLUMES

  • JAMJOOM PHARMA - QUARTER SAW FAVORABLE PRODUCT MIX ACROSS STRATEGIC BRANDS AND SALES GROWTH ACROSS KEY MARKETS

Source text: ID:nSSEbpRMZJ

Further company coverage: 4015.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.